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Abstract
Axon growth is an essential process during brain development. The E3 ubiquitin ligase Cdh1-APC has emerged as a critical
regulator of intrinsic axon growth control. Here, we identified the RhoGAP p250GAP as a novel interactor of the E3 ubiquitin
ligase Cdh1-APC and found that p250GAP promotes axon growth downstream of Cdh1-APC. We also report that p250GAP
undergoes non-proteolytic ubiquitination and associates with the Cdh1 substrate Smurf1 to synergistically regulate axon
growth. Finally, we found that in vivo knockdown of p250GAP in the developing cerebellar cortex results in impaired
migration and axonal growth. Taken together, our data indicate that Cdh1-APC together with the RhoA regulators p250GAP
and Smurf1 controls axon growth in the mammalian brain.
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Introduction
Axon growth is a fundamental process in the developing
nervous system [1–3]. The ubiquitin proteasome system (UPS) has
emerged as a key player in neuronal development [4,5]. A growing
number of E3 ubiquitin ligases have been implicated in axon
growth and guidance, in addition to other crucial neurodevelop-
mental events including neurogenesis, polarity, migration, den-
dritic growth, synapse formation, and memory [6–16].
The multisubunit E3 ubiquitin ligase Cdh1-APC, a crucial cell
cycle regulator in mitotic cells, acts as a suppressor of axon growth
in neurons [12]. Several studies have delineated an intricate
mechanism by which Cdh1-APC exerts a strong intrinsic in-
hibition of axon growth [17–21]. Like in mitotic cells, Cdh1-APC
targets several substrates for proteasomal degradation in neurons
to control axon growth suppression. The transcriptional regulators
SnoN and Id2 and the E3 ligase Smurf1 have been identified as
bona fide, signature D-box motif-harboring substrates [16,19,22].
While SnoN and Id2 are nuclear targets of Cdh1 in axon growth
control [17,19], Smurf1 acts both in the nucleus and cytoplasm to
stimulate axon growth [16]. Importantly, cytoplasmic Smurf1
targets the small GTPase RhoA for degradation [6,23]. RhoA,
which is instrumental to axon formation, axon growth and
guidance, and neuronal migration [24,25], relays myelin-induced
axon growth inhibition [26,27] and has emerged as a crucial
intrinsic suppressor of axon growth downstream of the Cdh1-
APC/Smurf1 pathway [16]. Although Cdh1-APC’s activity is
crucial in the nucleus to control axon growth [17], regulation of
RhoA at the axonal growth cone arose as an important aspect in
Cdh1-APC-mediated axon growth inhibition. Kannan and
colleagues recently identified a novel pathway, in which Cdh1-
APC acts upstream of the E3 ligase for RhoA, Smurf1 [16].
While Cdh1-APC targets the RhoA-E3 ligase Smurf1 for
degradation, we reasoned that Cdh1 may also interact with and
control regulators of RhoA activity owing to the opposing effect of
constitutively active RhoA on Cdh1 knockdown-enhanced axon
growth [16]. The activity of Rho GTPases switches from an active
to an inactive state and vice versa, which is tightly controlled by
specific binding of GAPs (GTPase activating proteins) and GEFs
(guanine nucleotide exchange factors), respectively. Hence we
carried out a RhoGAP interaction screen and identified the
RhoGAP p250GAP as a novel interactor of the E3 ubiquitin ligase
Cdh1-APC. p250GAP promotes axon growth downstream of
Cdh1-APC and in a synergistic manner with Smurf1. Finally, we
demonstrate that p250GAP and Smurf1 promote axon growth
and migration in the developing mammalian nervous system.
Results
The RhoGAP p250GAP is a Novel Interactor of Cdh1
We have previously characterized a novel Cdh1-APC/Smurf1
pathway of axon growth, in which RhoA emerged as a crucial
downstream component of intrinsic axon growth suppression [16].
This prompted us to investigate other regulators of RhoA and
more specifically their interaction with Cdh1. Since both Cdh1-
APC and RhoA negatively regulate axon growth, we hypothesized
that a Rho GTPase activating protein (GAP) would meet the
requirement to establish a connection between Cdh1-APC and
RhoA. We thus selected brain-abundant GAPs, which were
previously implicated in neuronal morphogenesis, and screened
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those for an association with Cdh1. In coimmunoprecipitation
experiments, we analyzed the association of Cdh1 with the
RhoGAPs Nadrin, p190GAP, GRAF, oligophrenin and p250GAP
in heterologous cells. Among these GAPs, we found a robust
association of Cdh1 and p250GAP (Figure 1A, Figure S1A–E).
In reciprocal analysis, we immunoprecipitated p250GAP and
found that Cdh1 interacts with p250GAP (Figure 1B). In
addition, we found that Cdh1 and p250GAP associate endoge-
nously in the brain (Figure 1C). These data identify the RhoGAP
p250GAP as a novel interactor of Cdh1.
p250GAP is highly enriched in the brain (Figure 1D), [28] and
has been identified as a GAP, which regulates both RhoA and
Cdc42 activity in neurons [28,29]. To examine the temporal
expression of p250GAP in the cerebellum, we isolated rat cerebella
at different ages and immunoblotted lysates with the p250GAP
antibody and found that while p250GAP is abundantly expressed
in early developmental stages, its levels decrease over time
Figure 1. Brain-dominant p250GAP associates with Cdh1. A. 293T cells transfected with control vector pcDNA3 and HA-Cdh1, or control
pCMV5 vector and Myc-p250GAP, or both HA-Cdh1 and Myc-p250GAP plasmids, were lysed and lysates subjected to immunoprecipitation with the
HA antibody and immunoblotting with the Myc antibody. B. Lysates of 293T cells transfected with control vector pcDNA3 and GFP-Cdh1, or GFP and
Myc-p250GAP plasmid, or plasmids encoding GFP-Cdh1 and Myc-p250GAP were subjected to immunoprecipitation with the Myc antibody followed
by immunoblotting with the GFP antibody. C. Total brain lysate from P9 mouse was subjected to immunoprecipitation with control serum or Cdh1
antiserum followed by immunoblotting with p250GAP antiserum. Arrow indicates p250GAP and asterisk IgGH. D. Lysates of indicated tissues were
collected from wild type P60 mouse and subjected to immunoblotting using the p250GAP antibody. Akt served as loading control. Asterisks indicate
p250GAP. E. Cerebella were collected from wild type rats at the indicated days and the lysates were subjected to immunoblotting using the p250GAP
antibody. c-tubulin served as loading control. E = embryonic, P =postnatal. F. Granule neurons were transfected at DIV 1 with GFP-p250GAP and at
DIV 3 subjected to immunocytochemistry with the GFP antibody and the nuclear dye bisbenzimide Hoechst 33258. Arrows and asterisk indicate
axons and soma, respectively. Scale bar equals 10 mm. G. Cerebellar granule neurons were subjected to subcellular fractionation at DIV 3. Nuclear
(NF) and postnuclear supernatant (PNS) fractions were immunoblotted using p250GAP, SnoN and 14-3-3b antibodies. SnoN and 14-3-3b served as
controls for NF and PNS, respectively.
doi:10.1371/journal.pone.0050735.g001
Cdh1-APC/p250GAP/Smurf1 Pathway of Axon Growth
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Figure 2. p250GAP promotes axon growth. A. Lysates of 293T cells transfected with GFP-p250GAP plasmid together with control vector U6 or
the p250GAP RNAi plasmid were subjected to immunoblotting using the GFP antibody. c-tubulin served as the loading control. B. Cerebellar granule
neurons were transfected at DIV 0 with control vector U6 or the p250GAP RNAi plasmid together with GFP and BCLXL plasmids and maintained in
Cdh1-APC/p250GAP/Smurf1 Pathway of Axon Growth
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(Figure 1E). At the subcellular level, expression of GFP-p250GAP
demonstrates a cytoplasmic localization of p250GAP in granule
neurons (Figure 1F). This finding was supported by subcellular
fractionation analyses of granule neuron lysates revealing
p250GAP as a cytoplasmic protein (Figure 1G). Taken together
these experiments characterize p250GAP as a brain-enriched,
cytoplasmic protein.
p250GAP Promotes Axon Growth
Owing to p250GAP’s neuronal expression and interaction with
Cdh1, we took an RNAi approach to ask whether p250GAP plays
a role in axon growth regulation. Nakazawa and colleagues
previously identified a targeting region in p250GAP [29], which
we utilized to generate a plasmid encoding a p250GAP hairpin.
We confirmed the efficient knockdown of GFP-tagged p250GAP
in heterologous cells (Figure 2A) prior to transfection of granule
neurons with the control plasmid or the p250GAP RNAi plasmid.
Axon growth measurements of p250GAP knockdown neurons
uncovered a significant reduction in axonal length as compared to
control neurons (Figure 2B, C). To determine that this
phenotype can be specifically attributed to knockdown of
p250GAP and to rule out off-target effects, we validated an
RNAi-resistant form of p250GAP (human (h)p250GAP) with
immunoblotting (Figure 2D). Then we carried out rescue
experiments and coexpressed the RNAi-resistant form of
p250GAP in the background of p250GAP knockdown and found
that axonal length is restored to baseline length of control neurons
(Figure 2E, F).
To establish a Cdh1/p250GAP pathway of axon growth
control, we carried out epistasis analyses. We found that while
Cdh1 knockdown promotes and p250GAP RNAi inhibits axon
growth, the p250GAP RNAi phenotype overrules the enhance-
ment of axon growth triggered by Cdh1 knockdown (Figure 2G,
H), indicating that p250GAP acts downstream of Cdh1-APC.
p250GAP is Ubiquitinated but not Degraded by the
Proteasome
To investigate if p250GAP is a substrate of Cdh1-APC, we
screened the p250GAP amino acid sequence for Cdh1 signature
binding motifs including D-box and KEN box. We found only one
potential D-box in the N-terminal half of p250GAP and reasoned
that since Cdh1 binds to the C-terminal part of p250GAP
(Figure 3A), this D-box is unlikely to be a bona fide one. Also,
mutation of the D-box does not alter the binding affinity of
p250GAP to Cdh1 (Figure S2). We then tested whether neuronal
p250GAP is sensitive to proteasome inhibition, which indicates
a proteasome-dependent turnover. We treated granule neurons
with the proteasome inhibitors lactacystin, bortezomib or with
vehicle, analyzed equal amounts of lysates with immunoblotting
using the p250GAP antibody and found that p250GAP fails to
respond to either inhibitor (Figure 3B, C), while Smurf1
responds to bortezomib (Figure 3C) and as shown previously to
lactacystin [16]. To further underscore that p250GAP may not be
a substrate of Cdh1-APC targeted for degradation, we analyzed
p250GAP levels in wild type and heterozygous Cdh1 gene trap
animals. Homozygous Cdh1 gene trap animals are not viable
owing to Cdh1’s essential function in cell cycle [30]. While we
previously found an accumulation of the Cdh1 target Smurf1 [16],
p250GAP levels are unaltered in lysates of P12 and W16
cerebellum of heterozygous animals as compared to wild type
littermates (Figure 3D). These data indicate that p250GAP is not
targeted for proteasomal degradation by Cdh1-APC.
To examine whether p250GAP might undergo non-proteolytic
and possibly activity-modifying ubiquitination, we first determined
in cell-based ubiquitination assays whether the p250GAP-N and
p250GAP-C deletion mutants are modified by ubiquitin. We
found in immunoprecipitation analysis that p250GAP-C but not
the p250GAP-N presents with a ubiquitin smear, suggesting the
modification by ubiquitin at the C-terminus (Figure 3E, F). In
cell-based ubiquitination assays, we found that expression of Cdh1
selectively enhances the ubiquitination of p250GAP-C but not
p150GAP-N (Figure 3G, H). These results suggest that Cdh1
stimulates the ubiquitination of p250GAP.
A p250GAP-ubiquitin Fusion Protein is Rendered Non-
functional in Axon Growth Stimulation
Functional modification of proteins by ubiquitination including
monoubiquitination has been demonstrated for other proteins e.g.
the GTPase Rap2a, which undergoes mono- or diubiquitination
by the E3 HECT ligase NEDD4 in the control of neurite
development [31]. To test the idea of functional modification of
p250GAP by ubiquitination, we constructed two p250GAP fusion
proteins, one that harbors an N-terminal ubiquitin and one that
harbors ubiquitin at the C-terminus. Previous experiments have
established that an N-terminal ubiquitin moiety subjects a protein
to the N-end rule of protein degradation by the proteasome, while
a C-terminally appended ubiquitin results in stabilization [32,33].
Our experiments revealed that the ubiquitin-p250GAP fusion
protein is highly unstable. p250GAP-ubiquitin however is as stable
as the wild type p250GAP (Figure 4A). We subsequently
immunoprecipitated p250GAP WT, ubiquitin-p250GAP or
p250GAP-ubiquitin, followed by immunoblotting using the
ubiquitin antibody and found that while N-terminal ubiquitination
of p250GAP produces a degradation smear, p250GAP-ubiquitin
displays a high molecular weight smear above 250kD and wild
type p250GAP exhibits a lesser extent of ubiquitin reactivity
(Figure 4B). To determine whether appending ubiquitin to
p250GAP results in a change of function, we carried out a rescue
analysis in an analogous experiment as described in Figure 2E.
We expressed wild type p250GAP, ubiquitin-p250GAP or
p250GAP-ubiquitin in the background of p250GAP RNAi and
found again restoration of axon growth by wild type p250GAP.
Expectedly, ubiquitin-p250GAP, which is prone to degradation,
results in loss-of-function (Figure 4C). Interestingly, the stable
conditioned media. At DIV 4, neurons were subjected to immunocytochemistry using the GFP antibody. Axonal length was measured in GFP-positive
transfected neurons using ImageJ software. A total of 300 neurons were measured (t-test, ***p,0.0001, values indicate mean+SEM). C.
Representative images of transfected neurons in B. Scale bar equals 100 mm. Arrows indicate axons. D. Lysates of 293T cells transfected with GFP-
tagged mouse (m)p250GAP or human (h)p250GAP together with control vector U6 or rodent-specific p250GAP RNAi plasmid were immunoblotted
with the GFP antibody. c-tubulin served as the loading control. E. Granule neurons were transfected at DIV 0 with control vectors pcDNA3 and U6, or
p250GAP RNAi together with pcDNA3 or human p250GAP plasmids. At DIV 4, neurons were analyzed as in 2B. A total of 273 neurons were measured
(t-test, ***p,0.0001, n.s. = not significant, values indicate mean+SEM). F. Representative images of transfected neurons in E. Scale bar equals 100 mm.
Arrows indicate axons. G. Granule neurons were transfected at DIV 0 with control U6, U6 and Cdh1 RNAi, or U6 and p250GAP RNAi or both Cdh1 RNAi
and p250GAP RNAi plasmids and were subjected to axon growth assays at DIV4 as described in 2B. A total of 635 neurons were measured (ANOVA,
***p,0.0001, n.s. = not significant, values indicate mean+SEM). H. Representative images of transfected neurons in G. Scale bar equals 100 mm.
Arrows indicate axons.
doi:10.1371/journal.pone.0050735.g002
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Figure 3. p250GAP is ubiquitinated but not degraded by the proteasome. A. 293T cells were transfected with GFP-Cdh1 together with
control vector pCMV-Myc, or plasmids encoding Myc-tagged full length, N- or C-terminal fragments of p250GAP (Myc-p250GAP, Myc-p250GAP-N or
Cdh1-APC/p250GAP/Smurf1 Pathway of Axon Growth
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version of p250GAP, p250GAP-ubiquitin falls short to rescue axon
growth (Figure 4C and Figure 4D). Our data support the
notion that by undergoing C-terminal ubiquitination, p250GAP is
stable but fails to promote axon growth.
Epistasis Analyses of p250GAP- and Smurf1-regulated
Axon Growth
To establish a relationship between Cdh1-APC, p250GAP and
the previously identified substrate Smurf1 [16], we went on and
tested whether Smurf1 and p250GAP may interact, since both
proteins are regulators of RhoA [23,28]. Strikingly, we found that
Smurf1 associates with p250GAP (Figure 5A, B). We then
examined whether Smurf1 and p250GAP synergistically control
axon growth and triggered p250GAP/Smurf1 double knockdown
and compared axon length to p250GAP or Smurf1 knockdown or
control-transfected neurons. We found that p250GAP double
knockdown does not result in significantly shorter axons as
compared to single knockdown neurons, suggesting a synergistic
effect of p250GAP and Smurf1 in axon growth control
(Figure 5C). We also investigated which of the two proteins
exerts the dominant phenotype. Interestingly, we found that
knockdown of p250GAP nullifies the enhancement of axon growth
by Smurf1 DBM3/4 (Figure 5D, E). These experiments indicate
that Smurf1 and p250GAP synergistically regulate axon growth
downstream of Cdh1-APC.
Smurf1 and p250GAP Control Axon Growth and
Migration in the Developing Cerebellum
Finally, we explored the role of p250GAP in axonal de-
velopment in the cerebellar cortex using the in vivo electroporation
techniques [12,17]. We injected bicistronic plasmids encoding
p250GAP targeting hairpins and an EGFP expression cassette,
which were validated for efficient knockdown (Figure 6A), into
the cerebellum of postnatal day 4 rat pups and subjected the
animals to repeated electric pulses. Five days later, we analyzed
coronal sections of control and knockdown animals. In control
animals, the GFP-positive granule neurons descend into the
internal granule layer, form bifurcated axons and develop
a dendritic arbor. We have previously shown that Smurf1
knockdown results in axon growth and migration defect [16].
Here, we discovered that both knockdown of p250GAP and
p250GAP/Smurf1 double knockdown display an overt phenotype,
in which granule neurons are stalled in the molecular layer. When
we quantified the migration defect, we found that more than 90%
of control neurons migrate into the internal granule layer, while
only 43% of p250GAP knockdown neurons descend (Figure 6B,
C). The double knockdown revealed an even more dramatic
failure of neurons to migrate. Here, only 30% reach the internal
granule layer, possibly as consequence of additive effects of
p250GAP- and Smurf1-regulated migration (Figure 6B). In
addition, we observed that stalled neurons extend shorter and
rather thick axons, which fail to develop into the parallel fibers.
The quantification of thick and thin processes demonstrated a clear
defect in p250GAP as well as the p250GAP/Smurf1 double
knockdown neurons, suggesting that p250GAP and Smurf1 are
required for the proper development of parallel fibers (Figure S3).
Furthermore, we determined axon length of the transfected
neurons. Since it is impossible to measure the entire length of
parallel fibers of control neurons, we determined the minimal
length of these processes by measuring the length of the parallel
fibers for as long as we could trace them in the given sections. In
the knockdown conditions however, we could determine the tips of
the short grown axons and measure their lengths. We found that
control axons extend for at least 440 mm, while knockdown of
p250GAP or double knockdown results in an average length of
90 mm and 106 mm, respectively (Figure 6D, E). Taken together,
the in vivo analyses demonstrate that p250GAP and Smurf1
promote proper migration and axon elongation in the developing
cerebellar cortex.
Discussion
In this study, we provide further insight into Cdh1-APC
controlled axon growth in the mammalian brain. We identified the
RhoGAP p250GAP as a novel interactor of Cdh1, that acts
downstream of Cdh1 in axon growth regulation. Our data also
suggest an interaction and a synergistic action of p250GAP and
Smurf1. Finally, we report an axon growth- and migration-
stimulating role of p250GAP in the developing cerebellar cortex.
Our previous finding that regulation of the small GTPase RhoA
by Smurf1 is an important event in the Cdh1-APC pathway of
axon growth suppression [16], led us to discover the GTPase
activating protein (GAP) p250GAP as a novel interactor of Cdh1.
p250GAP is a large, brain-enriched GAP, which hydrolyses
RhoA-GTP and Cdc42-GTP and was found to regulate neurite
growth in a neuroblastoma and PC12 cell line [28,29,34]. In
mature neurons, p250GAP also localizes to dendritic spines to
regulate their morphology in an NMDA-receptor mediated
manner [29]. Our study revealed that p250GAP operates
downstream of Cdh1-APC to promote axon growth. The finding
that Smurf1 and p250GAP act synergistically in axon growth
indicates that the regulation of RhoA by protein turnover and
GAP-dependent inactivation is required for axon growth stimu-
lation. The role of p250GAP in neurite growth was investigated in
another study, which employed mouse genetics to examine RICS
(p250GAP) in neurons isolated from knockout animal. Here, the
authors proposed that RICS (p250GAP) inhibits neurite growth
and that it acts as a GAP for Cdc42 and Rac1 but not RhoA [35].
This is however inconsistent with our study and with the findings
of Nakazawa and colleagues, which propose that p250GAP
enhances axon growth and that, p250GAP acts on RhoA,
respectively.
Myc-p250GAP-C) and the lysates were subjected to immunoprecipitation with the Myc antibody followed by immunoblotting with the GFP antibody.
B. Granule neurons treated with vehicle or 5 mM lactacystin for 10 h following which lysates were subjected to immunoblotting using the p250GAP
antibody. c-tubulin served as the loading control. C. Lysates of granule neurons treated with vehicle or 10 nM bortezomib for 10 h were subjected to
immunoblotting using the p250GAP or Smurf1 antibodies. c-tubulin and 14-3-3b served as loading controls, respectively. D. Cerebellar lysates of
postnatal day (P) 12 and week (W) 16 Cdh1+/+ and Cdh1+/2mice were immunoblotted using the p250GAP antibody. Erk1/2 served as loading control.
E. 293T cells were transfected with control vector pCMVmyc, Myc-p250GAP-N or Myc-p250GAP-C plasmid and the lysates were immunoprecipitated
using the Myc antibody followed by immunoblotting with ubiquitin antibody. Asterisk indicates IgGH. F. Intensity of p250GAP ubiquitination in each
condition in B was quantified and normalized to that of control using ImageJ software (ANOVA, **p,0.01, n.s. = not significant, values indicate
mean+SEM). G. 293T cells were transfected with control vectors pCMV-Myc and pEGFP, Myc-p250GAP-N plasmid together with pEGFP or GFP-Cdh1
plasmid, or Myc-p250GAP-C plasmid together with pEGFP or GFP-Cdh1 plasmid and the lysates were immunoprecipitated using the Myc antibody
followed by immunoblotting with ubiquitin antibody. Asterisk indicates IgGH. H. Intensity of p250GAP ubiquitination in each condition in D was
quantified and normalized to that of control using ImageJ software (ANOVA, *p,0.05, **p,0.01, values indicate mean+SEM).
doi:10.1371/journal.pone.0050735.g003
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Our study does not support the notion that p250GAP
undergoes degradation-initiating ubiquitination as p250GAP pro-
tein levels neither respond to proteasome inhibition nor to half of
the Cdh1 gene dosage in the cerebellum. It is thus likely that
p250GAP’s ubiquitin modification alters its function. Here, one
could envision two plausible scenarios of how ubiquitinated
p250GAP fails to promote axon growth: Ubiquitination may
render p250GAP inactive as a RhoGAP, which is then unable to
inactivate RhoA, or ubiquitinated p250GAP may no longer be
able to bind to RhoA and consequently fails to act as a RhoGAP.
Non-proteolytic ubiquitination resulting in inactivation or activa-
tion has been demonstrated for example in transcriptional
regulation [36]. In the brain, Kawabe and colleagues discovered
that mono- or diubiquitination of small GTPase Rap2a in neurons
triggers inactivation followed by inhibition of dendritic growth
[31]. We found that a p250GAP-ubiquitin fusion protein exhibits
a loss-of-function to promote axon growth, supporting a potential
inactivation as a consequence of Cdh1-mediated ubiquitination.
Figure 4. p250GAP-ubiquitin displays loss-of-function in axon growth. A. 293T cells were transfected with pcDNA3 control vector, Myc-
p250GAP wild type (Myc-p250GAP WT), Myc-ubiquitin-p250GAP or Myc-p250GAP-ubiquitin plasmid and lysates were subjected to immunoblotting
using the Myc antibody. B. Lysates of 293T transfected with pcDNA3 control vector, Myc-p250GAP WT, Myc-ubiquitin-p250GAP or Myc-p250GAP-
ubiquitin plasmid were subjected to immunoprecipitation using the Myc antibody followed by immunoblotting with ubiquitin antibody. Asterisks
indicate ubiquitinated p250GAP and { indicates IgGH. C. Granule neurons were transfected at DIV 0 with the control vector pcDNA3 together with U6
or the p250GAP RNAi plasmid, or p250GAP RNAi together with p250GAP WT, Ubiquitin-p250GAP or p250GAP-ubiquitin plasmids. At DIV 4, neurons
were subjected to axon assays as described in 2B. A total of 533 neurons were measured (ANOVA, ***p,0.0001, n.s. = not significant, values indicate
mean+SEM). D. Representative images of transfected neurons in C. Scale bar equals 100 mm. Arrows indicate axons.
doi:10.1371/journal.pone.0050735.g004
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Interestingly, not only did we find that p250GAP and Smurf1
promote axon growth [16], we also identified the two as novel
interactors. This finding raises the question if this interaction is
dependent on RhoA. It is conceivable that RhoA mediates the
binding of Smurf1 and p250GAP, in particular given that Smurf1
preferentially binds to inactive or nucleotide-free RhoA [37] and
that the nature of p250GAP is to inactivate RhoA [28]. It is also
possible that owing to the large size of p250GAP, it acts as
a platform to recruit Smurf1 and to facilitate Smurf1’s access and
binding to RhoA.
In addition to axon growth, we found that p250GAP promotes
the proper migration of granule neurons in the cerebellum. The
RICS (p250GAP) knockout study however did not examine in vivo
developmental defects [35]. Further analyses of these mice might
Figure 5. Association of p250GAP with Smurf1 regulates axon growth. A. 293T cells were transfected with control vector pCMV5 and Myc-
p250GAP, or control pcDNA3 vector and HA-Smurf1, or both HA-Smurf1 and Myc-p250GAP plasmids and the lysates were subjected to
immunoprecipitation with the Myc antibody followed by immunoblotting with the HA antibody. B. Reciprocal co-immunoprecipitation of A. C.
Granule neurons transfected with control U6, U6 and Smurf1 RNAi, or U6 and p250GAP RNAi or both Smurf1 RNAi and p250GAP RNAi plasmids were
analyzed at DIV 4 as described in 2B. A total of 467 neurons were measured (ANOVA, ***p,0.0001, n.s. = not significant, values indicate mean+SEM).
D. Granule neurons transfected with control U6, pCMV5 and p250GAP RNAi, or U6 and Smurf1 DBM3/4 or both p250GAP RNAi and Smurf1 DBM3/4
plasmids were subjected to axon growth assays at DIV 4 as described in 2B. A total of 324 neurons were measured (ANOVA, ***p,0.0001, n.s. = not
significant, values indicate mean+SEM). E. Representative images of transfected neurons in D. Scale bar equals 100 mm. Arrows indicate axons.
doi:10.1371/journal.pone.0050735.g005
Cdh1-APC/p250GAP/Smurf1 Pathway of Axon Growth
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Figure 6. p250GAP promotes migration and axon extension in the developing cerebellar cortex. A. Lysates of 293T cells transfected
with control vector U6-CMV-EGFP or U6-p250GAP RNAi-CMV-EGFP (p250GAP RNAi) together with GFP-p250GAP expression plasmid were subjected
to immunoblotting with GFP and c-tubulin (loading control) antibodies. B. The control U6-CMV-EGFP plasmid, p250GAP RNAi-CMV-EGFP (p250GAP
Cdh1-APC/p250GAP/Smurf1 Pathway of Axon Growth
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be informative and important owing to the role of p250GAP in
spine development and migration and possible cognitive defects
resulting thereof. Our in vivo analyses demonstrate that p250GAP/
Smurf1 double knockdown leads to a severe defect in axon growth
and in addition a striking impairment of granule neuron migration
in the developing cerebellum. Individual knockdown of p250GAP
and Smurf1 both revealed an overt short axon phenotype and no
enhancement of this effect in the double knockdown suggesting
that p250GAP and Smurf1 act synergistically in axon growth
control. In migration however, the p250GAP/Smurf1 double
knockdown results in an additive effect reflected by a more severe
migration defect. This led us to conclude that they may function in
parallel pathways to regulate migration. While Smurf1 and
p250GAP may mostly target RhoA to control axon growth, the
regulation of migration by Smurf1 and p250GAP may occur by
targeting other substrates and Rho family members, respectively.
Smurf1 has previously been identified as an E3 ligase for Par6 [6],
and Par6 in turn is known to be involved in neuronal migration
[38]. Also, in addition to RhoA, p250GAP has been demonstrated
to act on Cdc42 [28], whose role in neuronal migration has been
reported [39,40]. Taken together our findings underscore the
crucial role of RhoA regulators in the developing mammalian
brain and the importance of the tight regulation of RhoA by the
Cdh1-APC/p250GAP/Smurf1 pathway (Figure 7). A recent
report suggests that the Cdh1 target SnoN also controls migration
as SnoN knockdown affects the positioning in the internal granule
layer of the cerebellum [41], indicating that Cdh1-APC governs




All experiments involving live animals have been conducted
according to the animal protocol approved by the ‘‘Verbrau-
cherschutz und Lebensmittelsicherheit’’ of Lower Saxony, Ger-
many (33.11.42502-04-058/08).
Plasmids and Reagents
The Cdh1 RNAi, Smurf1 RNAi and Smurf1 DBM3/4
expression plasmids have been described previously [12,16]. The
p250GAP RNAi plasmid was generated by cloning a previously
described p250GAP targeting region [29] into a modified pBlue-
script-U6 plasmid. Myc-p250GAP-N and Myc-p250GAP-C
plasmids were generated by cloning fragments 1–2580 and
2581–5214, respectively into pCMVmyc plasmid. Myc-ubiqui-
tin-p250GAP and Myc-p250GAP-ubiquitin fusion constructs were
obtained by sub-cloning human ubiquitin from a pCMV5-HIS-
ubiquitin plasmid into the pcDNA3-Myc-p250GAP plasmid.
RNAi), or p250GAP RNAi and Smurf1 RNAi-CMV-EGFP (Smurf1 RNAi) plasmids together with BCLXL plasmid were injected into the cerebellum of P4 rat
pups. At P9, cerebella were isolated and coronal sections were subjected to immunohistochemistry using the GFP antibody. The location of
transfected neurons was assessed as either external granule layer (EGL)/molecular layer (ML) or internal granule layer (IGL). A total of 10527 neurons
were counted (ANOVA, **p,0.01, ***p,0.0001, values indicates mean+SEM). C. Representative images of each condition in B. Scale bar equals
100 mm. Arrows indicate parallel fibers and processes and arrowheads indicate cell bodies. D. Quantification of axonal length of neurons in the
control, p250GAP knockdown and p250GAP/Smurf1 double knockdown conditions. A total of 325 neurons were measured (ANOVA, ***p,0.0001,
values indicate mean+SEM). E. Representative images of the knockdown conditions in C. EGL = external granule layer, ML =molecular layer,
IGL = internal granule layer. Scale bar equals 100 mm. Arrows indicate parallel fibers and processes.
doi:10.1371/journal.pone.0050735.g006
Figure 7. Schematic of Cdh1-APC-regulated axon growth. The E3 ubiquitin ligase Cdh1-APC operates upstream of the RhoA-regulating
proteins Smurf1 and p250GAP in the control of axon growth. While Cdh1-APC ubiquitinates Smurf1 for proteasomal degradation, it ubiquitinates
p250GAP for a functional modification in RhoA-dependent axon growth inhibition.
doi:10.1371/journal.pone.0050735.g007
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Primary Neuron Culture and Transfections
Cerebellar granule neurons were isolated from Wistar rats at
postnatal day (P) 6 as described previously [42]. Neurons were
plated on polyornithine-coated glass coverslips and kept in Basal
Medium Eagle (BME) (Invitrogen, Carlsbad, CA) containing 10%
calf serum (Hyclone Laboratories, Logan, UT), 25 mM KCl and
2 mM penicillin, streptomycin and glutamine (PSG). At P6+1 day
in vitro (DIV), neurons were treated with 10 mM of the mitotic
inhibitor cytosine b-D-arabinofuranoside to inhibit proliferation of
non-neuronal cells. Granule neurons were transfected 8 h after
plating ( =DIV 0) using the modified calcium phosphate method
with indicated plasmids together with a GFP expression plasmid to
visualize transfected cells and a plasmid encoding the anti-
apoptotic protein Bcl-xl to rule out any effect of the genetic
manipulations on cell survival. Expression of Bcl-xl itself has little
or no effect on axon length [12]. For morphological assays,
neurons on 12 mm cover slips were transfected with a total of 2 mg
of plasmid together with 0.3 mg Bcl-xl and 0.2 mg GFP plasmids.
The respective empty vectors served as control. The transfection
ensures that at least 85% of the GFP-positive neurons co-express
two other plasmids. Transfected neurons were fixed in 4%
paraformaldehyde at DIV 4, permeabilized in 0.4% Triton-X100
in PBS and subjected to immunostaining using the rabbit GFP
antibody (Invitrogen, Carlsbad, CA) followed by a fluorophore-
conjugated anti-rabbit secondary antibody at 1:1000 dilution in
BME+10% horse serum.
Axon Growth Assays
Morphological assays were performed as described previously
[12] [17]. GFP-positive neurons were imaged by a blinded
observer using a Nikon Eclipse TS100 (Tokyo, Japan) epifluores-
cence microscope and axonal lengths were measured using ImageJ
software. Statistical tests (ANOVA or unpaired t-tests) were
performed using Graph Pad Prism 5.0c software.
Co-immunoprecipitation, Subcellular Fractionation,
Ubiquitination Assays and Immunoblotting
For co-immunoprecipitation assays, transfected 293T cells
(exogenous) or P9 mice cortices (endogenous) were lysed in buffer
containing 150 mM NaCl, 210 mM Tris pH 7.4, 1 mM EDTA,
1% NP40, 10% glycerol and fresh protease inhibitors. Lysates
were incubated with either c-Myc (Santa Cruz Biotechnology,
CA), HA (Covance, Princeton, NJ), Cdh1, or GFP (Invitrogen)
antibody at 4uC for 4 h in a tumbler and then with Protein A
Sepharose (GE Healthcare) beads for 1 h. The beads were washed
3 times with Triton-X100 buffer (50 mM Tris-HCl pH7.5, 1 M
NaCl, 1 mM EDTA, 1% triton-X100) and once with PBS. The
beads were finally boiled in SDS-Laemmli buffer to elute the
bound protein.
For subcellular fractionation, granule neurons in a 10 cm plate
were scraped into detergent-free buffer A (10 mM HEPES pH7.9,
10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, fresh protease
inhibitors) and mechanically sheared using a 2 ml dounce
homogenizer. Nuclei were spun down at 500 g, 4uC and the
postnuclear supernatant fraction was transferred to a fresh tube.
The nuclear pellet was washed twice in 0.1% NP40 supplemented
buffer A and then lysed in buffer B (20 mM HEPES pH7.9,
400 mM NaCl, 1 mM EDTA, 1 mM EGTA, fresh protease
inhibitors) and centrifuged at maximum speed at 4uC. The
supernatant was collected as the nuclear fraction.
For cell-based ubiquitination assays, transfected 293T cells were
lysed in a denatured modified RIPA buffer (50 mM Tris pH7.5,
150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycho-
late, 10 mM N-ethyl maleimide and fresh protease inhibitors) to
reduce detection of non-specific ubiquitination, as described
previously [43]. The lysates were incubated with the Myc antibody
at 4uC for 2 h and then with Protein A Sepharose beads for
45 min. The beads were washed 3 times with triton-X100 buffer
to remove any unbound protein and once with PBS. The bound
protein was eluted by boiling the beads in SDS-Laemmli buffer.
SDS-PAGE and Western blotting were performed as previously
described [18].
In Vivo Electroporation
In vivo electroporation was performed as previously described
[17]. Plasmid DNA in PBS (4 ml/animal) together with 0.3% fast
green was injected into the cerebellar cortex of P4 rat pups using
a 25 ml syringe (Hamilton, Bonaduz, Switzerland) with a 30-guage
needle. 16 mg of the U6-CMV-EGFP or p250GAP RNAi/Smurf1
RNAi-CMV-EGFP bicistronic plasmid and 4 mg Bcl-xL expres-
sion plasmid were injected per animal. Following DNA injection,
animals were subjected to repeated electric pulses (5 pulses of 155–
170 V for 50 ms with intervals of 950 ms) and allowed to recover
on a heating pad. Electroporated pups were returned to the
mother until P9. Coronal sections (40 mm) of cerebella were
subjected to immunohistochemistry using a mouse GFP antibody
(Santa Cruz). Approximately 90% of GFP-positive granule
neurons were associated with parallel fibers ( = parallel fiber index)
in the control condition [17].
Confocal Imaging
For confocal imaging of granule neurons transfected with GFP-
p250GAP, we used a Leica TCS SP2 confocal microscope with
a 63x oil objective.
Supporting Information
Figure S1 RhoGAP Screen. A. 293T cells were transfected
with control vector pEGFP and HA-Graf, pTB701 and GFP-
Cdh1 or HA-Graf and GFP-Cdh1 plasmids and lysates were
subjected to immunoprecipitation with the HA antibody followed
by immunoblotting with GFP antibody. B. 293T cells were
transfected with control vector pEGFP and HA-Cdh1, pCMV5
and GFP-Nadrin or HA-Cdh1 and GFP-Nadrin plasmids and
lysates were subjected to immunoprecipitation with the HA
antibody followed by immunoblotting with GFP antibody. C.
293T cells were transfected with control vector pcDNA3.1 and
HA-Cdh1, pCMV5 and Myc-Ophn1 or HA-Cdh1 and Myc-
Ophn1 plasmids and lysates were subjected to immunoprecipita-
tion with the HA antibody followed by immunoblotting with Myc
antibody. D. 293T cells were transfected with control vector
pKH3 and GFP-Cdh1, pEGFP and HA-p190GAP or GFP-Cdh1
and HA-p190GAP plasmids and the lysates were subjected to
immunoprecipitation with the GFP antibody followed by immu-
noblotting with the HA antibody. E. 293T cells were transfected
with control vector pcDNA3 and HA-Cdh1, pCMV5 and Myc-
p250GAP or HA-Cdh1 and Myc-p250GAP plasmids and lysates
were subjected to immunoprecipitation with the HA antibody
followed by immunoblotting with Myc antibody.
(TIF)
Figure S2 Cdh1 interacts with p250GAP D-box mutant.
Lysates of 293T cells transfected with GFP-Cdh1 plasmid together
with control vector pcDNA3, Myc-p250GAP wild-type (Myc-
p250GAP WT) or the putative D-box mutant (Myc-p250GAP
DBM) were subjected to immunoprecipitation using the Myc
antibody followed by immunoblotting with the GFP antibody.
(TIF)
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Figure S3 Quantification of processes in the developing
cerebellar cortex. A. Quantification of thin (normal) processes
and short, thick processes in control, p250GAP knockdown and
p250GAP/Smurf1 double-knockdown conditions. A total of 1200
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